Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The atrioventricular (AV) interval, or AV nodal conduction timing, is a physiological parameter representing the duration of electrical impulse transmission from the atria to the ventricles. This delay is primarily mediated by the AV node and is essential for coordinating atrial and ventricular contraction to optimize cardiac output (StatPearls: Physiology, Atrioventricular Node). While not a single molecular entity, it is a critical functional target for rate-control therapy in conditions such as atrial fibrillation and supraventricular tachycardia (NCBI: Cardiac Conduction System). Drugs modulate this timing by acting on various molecular components within the AV node, including L-type calcium channels, beta-adrenergic receptors, and muscarinic receptors (PubMed: Pharmacological modulation of AV conduction). Clinically, this interval is monitored via the PR interval on an electrocardiogram (ECG). Excessive slowing of AV conduction can lead to heart block, a serious condition that may require pacemaker intervention or the cessation of offending medications (Merck Manual: Atrioventricular Block). Understanding the factors that influence AV nodal conduction is vital for both therapeutic efficacy and safety assessment in drug development.
Modulation of AV nodal conduction through inhibition of L-type calcium channels, antagonism of beta-1 adrenergic receptors, or activation of adenosine A1 receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atrioventricular nodal conduction timing (AV interval) (AV interval).